Stemtech Corp
corporate_fare Company Profile
Stemtech Corp (OTC:STEK) is a publicly traded company in the Trade & Services sector. Wiseek has independently scored 6 items for STEK at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-13, rated 8/10. Across its 6 most recent items scored 7 or higher, the top rating is 9/10, with 6 rated 8 or above. Recent SEC coverage for STEK spans 10-Q, 10-K.
Recent high-impact activity:
- Stemtech Q3: Going Concern Warning, MCA Defaults, Share Count Up 7x to 3.0B
- Stemtech Q2 Revenue Falls 9.8%, Shares Outstanding Surge 543% as Convertible Debt Converts
- Stemtech Q1 Revenue Drops 47% to $463K, Net Loss Narrows Despite Sales Decline
- Stemtech Reports Q1 Loss Amid 450% Share Dilution, Going Concern Warning, and Control Weaknesses
- Stemtech Revenue Plunges 43% to $2.88M in FY25 Amid Supply Issues
Financial Snapshot
Short Interest & Short Volume
1.00 days to coverFINRA reported short interest of 147 shares in STEK as of the October 30, 2026 settlement, a 99.9% decrease from the prior period — about 1.0 days to cover at its recent average daily volume. On November 20, 2026, 54.0% of STEK volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Moderate riskFiling-implied dilution signals for STEK, detected from its recent SEC filings · based on capital-structure filings through 2026-06-22.
Massive Share Dilution · Continued Going Concern Warning
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →